Jolanda de Vries, Dept. of Tumor Immunology, theme Cancer development and immune defense has been awarded the 2017 Huibregtsen Prize for her work on natural dendritic cell vaccines. This award is given to a research project that is scientifically innovative and benefits society.Jolanda de Vries investigates the role of dendritic cells in the defence against various forms of cancer and studies the effectiveness of dendritic cell therapy. Dendritic cells play an important role in immune responses. In response to infection or inflammation, and in response to cancer, dendritic cells undergo a complicated maturation process, after which they ultimately present fragments (proteins) from the pathogens or cancer cells to T cells in the lymph nodes. These are the ‘killer cells’ of the immune system. Due to the priming from the dendritic cells, they are able to recognise and attack cancer cells.
About the prize (in Dutch)
Film about the research (in Dutch)
Vaccine to target cancer cellsFrom these dendritic cells, de Vries developed a vaccine against cancer. For this purpose, dendritic cells are removed from the patient and taken to the laboratory where they are primed with tumour proteins. These cells are then returned to the patient, causing the T cells to attack the targeted tumour cells. The major benefit of this therapy is that it attacks tumour cells throughout the body with very few side effects, partly because the T cells are natural to the patient’s body.
The only one in the world, entirely on her ownThe jury of the Huibregtsen Prize stressed that Jolanda de Vries is currently the only researcher in the world who is carrying out studies based on natural dendritic cell-based vaccines. Remarkably, she has taken her research to patients entirely on her own, without the intervention of the pharmaceutical industry. The fact that the treatment with natural dendritic cell vaccines is provisionally paid for by basic health insurance is also exceptional. These aspects indicate how unique and important this work is.
About the Huibregtsen PrizeWinners of the Huibregtsen Prize receive a bronze sculpture, De Denker, created by Wil van der Laan, and a sum of € 25,000 to be spent on research. Previous winners of the Huibregtsen Prize from Nijmegen were professors Bart Jacobs (2012), Rutger Engels (2011) and Theo Rasing (2008).
Every year the prize is awarded as part of the Avond van Wetenschap & Maatschappij (‘Evening of Science and Society’), an annual event in the Ridderzaal in The Hague that is attended by leaders from science, culture, business, politics, media and sports, and is chaired by the Minister of Education, Culture and Science.
Related news items
Radium 223-mediated zonal cytotoxicity of prostate cancer in bone21 January 2019
In preclinical prostate carcinoma in the bone, Rad-223 eradicated effectively micro-tumors but macro-tumors persisted and expanded. The data point to application of Rad-223 in secondary prevention of early bone-metastatic disease and regimens co-targeting the tumor core.read more
COPAL reveals remodeling of mitochondrial protein complexes in Barth syndrome21 January 2019
Martijn Huijnen, theme Mitochondrial diseases, and colleagues developed COmplexome Profiling ALignment (COPAL) to systematically asses the effect of Barth syndome on mitochondrial protein complexes. They published their findings in Bioinformatics.read more
Adjunct Professorship awarded to Barbara Franke at the Goethe University in Frankfurt am Main21 January 2019
Barbara Franke is awarded an honorary Adjunct Professorship at the Goethe University in Frankfurt am Main in Germany.read more
Two papers on molecular mechanisms of GFI1B in inherited bleeding syndromes in Haematologica21 January 2019
Rinske van Oorschot from the Van der Reijden group, theme Cancer development and immune defense, has published two papers on the transcription factor GFI1B in Haematologica.read more
Blog: Species Differences The Elephant in the Room17 January 2019
Read the blog of Merel Ritskes-Hoitinga in the New England anti-vivisection society (neavs) based on a paper published in the Journal of Translational Medicine.read more
Bart-Jan Kullberg nominated for ZonMw Medical Inspirator Award17 January 2019
This prize is awarded for the most inspiring collaboration between patients and medical researchers. You can vote till 11 February.read more